Clinical Trial

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-15
notable Primary completion pushed: 2026-06-01 -> 2026-12-10 2026-08-15
minor Completion pushed: 2026-12 -> 2026-12-31 2026-08-15
Trial Details
NCT Number NCT06383585
Lead Sponsor Mayo Clinic
Collaborators: GE Healthcare
Conditions Inflammatory Arthritis
Enrollment 25 participants
Start Date 2024-12-05
Primary Completion 2026-12-10 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14